Sartorius reported EUR1.16 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.96 1.29 0.63 Oct/22
FY2026Q2 Jun/2026 0.95 1.36 0.47 Jul/24
FY2026Q1 Mar/2026 1.20 1.3 1.22 Apr/23
FY2025Q4 Dec/2025 1.27 1.33 1.04 Feb/03
FY2025Q3 Sep/2025 0.63 1.08 0.21 Oct/16




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.39 0.12 Jun/2026
Avita Medical AUD -0.25 0.13 Jun/2026
Dianthus Therapeutics USD -0.9 0.05 Jun/2026
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
IQVIA Holdings USD 3.34 0.19 Sep/2026
Moderna USD 0.38 2.35 Sep/2026
Organon & Co USD 0.6 0.2 Sep/2026
Revvity USD 1.37 0.04 Sep/2026
Sartorius EUR 1.16 0.21 Sep/2026
Tectonic Therapeutic USD -1.18 0.17 Jun/2026
Viatris USD 0.71 0.02 Sep/2026
Xeris Pharmaceuticals USD -0.18 0.19 Jun/2026